2002
DOI: 10.1148/radiol.2242011101
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Results 10 Years after Iliac Arterial Stent Placement

Abstract: The main cause of death in patients with intermittent claudication was cardiac disease. Long-term patency of iliac arterial stents was moderate.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
46
0
1

Year Published

2005
2005
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 73 publications
(51 citation statements)
references
References 16 publications
4
46
0
1
Order By: Relevance
“…The lesions occur typically at the aortic bifurcation, with disease extending into the origin of each common iliac artery. Stenoses are more common than occlusions by a 4:1 ratio [14].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The lesions occur typically at the aortic bifurcation, with disease extending into the origin of each common iliac artery. Stenoses are more common than occlusions by a 4:1 ratio [14].…”
Section: Discussionmentioning
confidence: 99%
“…Stenting is less feasible for infra-inguinal arterial lesions, because the long-term results of stenting are not better than those of PTA in spite of its good short-term results [14]. In a recent study that measured long-term outcomes of aortoiliac stent placement in treatment of 365 patients with chronic lower-extremity ischemia, primary patency was 74%, primary assisted patency 81%, and secondary patency 84%, eight years after stent placement [15].…”
Section: Discussionmentioning
confidence: 99%
“…Late results remain good, with long-term cumulative patency rates of up to 66% at 5 years [12]. In this respect, the best management of diffusely diseased and occluded iliac arteries is in flux.…”
Section: Percutaneous Treatment Strategiesmentioning
confidence: 98%
“…In this respect, the best management of diffusely diseased and occluded iliac arteries is in flux. • Iliac artery stenting has restenosis rates as low as 0.5%, as well as primary patency rates of 86% at 4 years [13], 66% at 5 years, and 46% at 10 years after the procedure [12]. The rationale behind stent use is to improve longterm outcomes compared with PTA alone, and to prevent abrupt vessel closure following complex interventions.…”
Section: Percutaneous Treatment Strategiesmentioning
confidence: 99%
“…Restenosis is the main drawback of endovascular treatment of the iliac and femoral arteries [1][2][3][4]. Conflicting experimental and clinical results have been reported for patency rates and restenosis in the iliofemoral arteries with different stent designs [5][6][7][8].…”
Section: Introductionmentioning
confidence: 99%